|
National Stock Number(NSN): 6505-00-138-3813 (6505001383813, 001383813)
| NIIN: |
00-138-3813 |
Item Name: |
HYDROFLUMETHIAZIDE AND RESERPINE TABLETS |
INC: |
32138
|
| FSC: |
6505
|
Assignment Date: |
Aug-09-1971 |
CRIT: |
X |
IIG: |
32138 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-31-2022 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9265 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00015-5436-60 |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC00725-0128-01 |
59389
|
CIRCA PHARMACEUTICAL CO INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
SALUTENSIN |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
5 |
1 |
6 |
54 |
3 |
D |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
50.000 MILLIGRAMS HYDROFLUMETHIAZIDE ACTIVE INGREDIENT AND 0.125 MILLIGRAMS RESERPINE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
100.000 TABLETS |
| CSGS |
ADMINISTRATION |
ORAL |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G57V |
|
Sep-01-1992 |
0 |
0 |
|
|
54 |
54|57 |
|